nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC3—lung cancer	0.221	0.707	CbGaD
Probenecid—ABCC6—Teniposide—lung cancer	0.0558	0.11	CbGbCtD
Probenecid—ALB—lung cancer	0.0468	0.15	CbGaD
Probenecid—ABCB1—lung cancer	0.0447	0.143	CbGaD
Probenecid—ABCC11—Methotrexate—lung cancer	0.0283	0.0557	CbGbCtD
Probenecid—ABCC6—Vinblastine—lung cancer	0.0273	0.0538	CbGbCtD
Probenecid—ABCC6—Cisplatin—lung cancer	0.025	0.0493	CbGbCtD
Probenecid—ABCC6—Etoposide—lung cancer	0.0246	0.0484	CbGbCtD
Probenecid—ABCC5—Cisplatin—lung cancer	0.0191	0.0377	CbGbCtD
Probenecid—ABCC6—Doxorubicin—lung cancer	0.0168	0.033	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—lung cancer	0.0124	0.0244	CbGbCtD
Probenecid—SLC16A1—Methotrexate—lung cancer	0.0124	0.0244	CbGbCtD
Probenecid—ABCC3—Cisplatin—lung cancer	0.012	0.0237	CbGbCtD
Probenecid—ABCC3—Etoposide—lung cancer	0.0118	0.0233	CbGbCtD
Probenecid—ABCC1—Paclitaxel—lung cancer	0.00918	0.0181	CbGbCtD
Probenecid—ABCC1—Irinotecan—lung cancer	0.00906	0.0178	CbGbCtD
Probenecid—SLC22A7—Docetaxel—lung cancer	0.00845	0.0166	CbGbCtD
Probenecid—ABCC3—Doxorubicin—lung cancer	0.00806	0.0159	CbGbCtD
Probenecid—ABCC1—Vinblastine—lung cancer	0.00805	0.0159	CbGbCtD
Probenecid—ALB—Gefitinib—lung cancer	0.00782	0.0154	CbGbCtD
Probenecid—ABCC3—Methotrexate—lung cancer	0.00781	0.0154	CbGbCtD
Probenecid—SLC22A2—Vinblastine—lung cancer	0.0073	0.0144	CbGbCtD
Probenecid—ABCC1—Etoposide—lung cancer	0.00725	0.0143	CbGbCtD
Probenecid—ABCC2—Paclitaxel—lung cancer	0.0068	0.0134	CbGbCtD
Probenecid—ABCC2—Irinotecan—lung cancer	0.0067	0.0132	CbGbCtD
Probenecid—SLC22A2—Cisplatin—lung cancer	0.00669	0.0132	CbGbCtD
Probenecid—ABCC1—Docetaxel—lung cancer	0.00664	0.0131	CbGbCtD
Probenecid—SLC22A11—Methotrexate—lung cancer	0.00641	0.0126	CbGbCtD
Probenecid—SLC22A7—Methotrexate—lung cancer	0.0061	0.012	CbGbCtD
Probenecid—ABCC4—Methotrexate—lung cancer	0.00596	0.0117	CbGbCtD
Probenecid—ABCC2—Vinblastine—lung cancer	0.00596	0.0117	CbGbCtD
Probenecid—ABCC2—Cisplatin—lung cancer	0.00546	0.0108	CbGbCtD
Probenecid—ABCC2—Etoposide—lung cancer	0.00537	0.0106	CbGbCtD
Probenecid—CYP2C19—Gefitinib—lung cancer	0.00507	0.00999	CbGbCtD
Probenecid—ABCC1—Doxorubicin—lung cancer	0.00495	0.00974	CbGbCtD
Probenecid—CYP2C19—Teniposide—lung cancer	0.00492	0.00969	CbGbCtD
Probenecid—ABCC2—Docetaxel—lung cancer	0.00491	0.00968	CbGbCtD
Probenecid—ABCC1—Methotrexate—lung cancer	0.00479	0.00944	CbGbCtD
Probenecid—ALB—Erlotinib—lung cancer	0.00463	0.00911	CbGbCtD
Probenecid—ABCB1—Topotecan—lung cancer	0.00447	0.00881	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—lung cancer	0.00428	0.00843	CbGbCtD
Probenecid—CYP2C9—Gefitinib—lung cancer	0.00422	0.00831	CbGbCtD
Probenecid—ALB—Irinotecan—lung cancer	0.00418	0.00823	CbGbCtD
Probenecid—ABCB1—Gefitinib—lung cancer	0.00409	0.00806	CbGbCtD
Probenecid—CYP2C9—Teniposide—lung cancer	0.00409	0.00805	CbGbCtD
Probenecid—SLC22A8—Methotrexate—lung cancer	0.00373	0.00734	CbGbCtD
Probenecid—ABCC2—Doxorubicin—lung cancer	0.00366	0.00721	CbGbCtD
Probenecid—CYP2C8—Erlotinib—lung cancer	0.00358	0.00704	CbGbCtD
Probenecid—ABCC2—Methotrexate—lung cancer	0.00355	0.00699	CbGbCtD
Probenecid—CYP2C8—Paclitaxel—lung cancer	0.00327	0.00644	CbGbCtD
Probenecid—ABCB1—Vinorelbine—lung cancer	0.00315	0.00621	CbGbCtD
Probenecid—CYP3A4—Topotecan—lung cancer	0.00268	0.00528	CbGbCtD
Probenecid—SLC22A6—Methotrexate—lung cancer	0.0026	0.00511	CbGbCtD
Probenecid—CYP2C8—Etoposide—lung cancer	0.00259	0.00509	CbGbCtD
Probenecid—ABCB1—Crizotinib—lung cancer	0.00251	0.00494	CbGbCtD
Probenecid—CYP3A4—Gefitinib—lung cancer	0.00245	0.00483	CbGbCtD
Probenecid—ABCB1—Gemcitabine—lung cancer	0.00245	0.00483	CbGbCtD
Probenecid—ABCB1—Erlotinib—lung cancer	0.00242	0.00477	CbGbCtD
Probenecid—ABCC11—mammary gland—lung cancer	0.00239	0.102	CbGeAlD
Probenecid—CYP3A4—Teniposide—lung cancer	0.00238	0.00468	CbGbCtD
Probenecid—CYP2C9—Paclitaxel—lung cancer	0.00228	0.0045	CbGbCtD
Probenecid—ABCB1—Paclitaxel—lung cancer	0.00222	0.00436	CbGbCtD
Probenecid—ALB—Methotrexate—lung cancer	0.00221	0.00435	CbGbCtD
Probenecid—ABCB1—Irinotecan—lung cancer	0.00219	0.0043	CbGbCtD
Probenecid—ABCB1—Vinblastine—lung cancer	0.00194	0.00383	CbGbCtD
Probenecid—CYP3A4—Vinorelbine—lung cancer	0.00189	0.00372	CbGbCtD
Probenecid—CYP2C9—Cisplatin—lung cancer	0.00184	0.00362	CbGbCtD
Probenecid—ABCB1—Cisplatin—lung cancer	0.00178	0.00351	CbGbCtD
Probenecid—ABCB1—Etoposide—lung cancer	0.00175	0.00345	CbGbCtD
Probenecid—ABCB1—Docetaxel—lung cancer	0.0016	0.00315	CbGbCtD
Probenecid—SLC2A9—respiratory system—lung cancer	0.0015	0.0644	CbGeAlD
Probenecid—CYP3A4—Crizotinib—lung cancer	0.0015	0.00296	CbGbCtD
Probenecid—CYP3A4—Erlotinib—lung cancer	0.00145	0.00286	CbGbCtD
Probenecid—CYP3A4—Paclitaxel—lung cancer	0.00133	0.00261	CbGbCtD
Probenecid—ABCC6—Podofilox—Teniposide—lung cancer	0.00133	0.627	CbGdCrCtD
Probenecid—CYP3A4—Irinotecan—lung cancer	0.00131	0.00258	CbGbCtD
Probenecid—PANX1—trachea—lung cancer	0.00123	0.0525	CbGeAlD
Probenecid—ABCB1—Doxorubicin—lung cancer	0.00119	0.00235	CbGbCtD
Probenecid—CYP3A4—Vinblastine—lung cancer	0.00116	0.00229	CbGbCtD
Probenecid—ABCB1—Methotrexate—lung cancer	0.00116	0.00228	CbGbCtD
Probenecid—CYP3A4—Etoposide—lung cancer	0.00105	0.00207	CbGbCtD
Probenecid—CYP3A4—Docetaxel—lung cancer	0.00096	0.00189	CbGbCtD
Probenecid—ABCC5—mammary gland—lung cancer	0.000931	0.0399	CbGeAlD
Probenecid—PANX1—lung—lung cancer	0.00088	0.0377	CbGeAlD
Probenecid—SLC2A9—lung—lung cancer	0.000798	0.0342	CbGeAlD
Probenecid—ABCC6—Podofilox—Etoposide—lung cancer	0.000789	0.373	CbGdCrCtD
Probenecid—SLC16A7—bronchus—lung cancer	0.00073	0.0313	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—lung cancer	0.000715	0.00141	CbGbCtD
Probenecid—ALB—mammary gland—lung cancer	0.000667	0.0286	CbGeAlD
Probenecid—SLC16A7—trachea—lung cancer	0.000655	0.0281	CbGeAlD
Probenecid—SLC16A7—cardiac atrium—lung cancer	0.000616	0.0264	CbGeAlD
Probenecid—PANX1—lymph node—lung cancer	0.000602	0.0258	CbGeAlD
Probenecid—SLC2A9—lymph node—lung cancer	0.000546	0.0234	CbGeAlD
Probenecid—ABCC3—respiratory system—lung cancer	0.000521	0.0223	CbGeAlD
Probenecid—ABCC5—bronchus—lung cancer	0.000511	0.0219	CbGeAlD
Probenecid—ABCC6—lung—lung cancer	0.000485	0.0208	CbGeAlD
Probenecid—SLC22A5—mammary gland—lung cancer	0.000484	0.0208	CbGeAlD
Probenecid—SLC16A1—epithelium—lung cancer	0.000472	0.0202	CbGeAlD
Probenecid—SLC16A7—lung—lung cancer	0.000471	0.0202	CbGeAlD
Probenecid—CYP2C8—mammary gland—lung cancer	0.000469	0.0201	CbGeAlD
Probenecid—Flushing—Teniposide—lung cancer	0.000458	0.00757	CcSEcCtD
Probenecid—Alopecia—Teniposide—lung cancer	0.000436	0.00721	CcSEcCtD
Probenecid—Anaphylactic shock—Pemetrexed—lung cancer	0.000433	0.00715	CcSEcCtD
Probenecid—ABCC5—cardiac atrium—lung cancer	0.000431	0.0185	CbGeAlD
Probenecid—CYP2C9—mammary gland—lung cancer	0.000416	0.0178	CbGeAlD
Probenecid—Anorexia—Pemetrexed—lung cancer	0.000413	0.00682	CcSEcCtD
Probenecid—Decreased appetite—Crizotinib—lung cancer	0.000412	0.0068	CcSEcCtD
Probenecid—Anorexia—Gefitinib—lung cancer	0.00041	0.00678	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Erlotinib—lung cancer	0.0004	0.00661	CcSEcCtD
Probenecid—Anaemia—Teniposide—lung cancer	0.000397	0.00656	CcSEcCtD
Probenecid—SLC16A1—cardiac atrium—lung cancer	0.000392	0.0168	CbGeAlD
Probenecid—Leukopenia—Teniposide—lung cancer	0.000385	0.00635	CcSEcCtD
Probenecid—Decreased appetite—Pemetrexed—lung cancer	0.000377	0.00622	CcSEcCtD
Probenecid—Haemolytic anaemia—Cisplatin—lung cancer	0.000375	0.0062	CcSEcCtD
Probenecid—Body temperature increased—Crizotinib—lung cancer	0.000375	0.00619	CcSEcCtD
Probenecid—Decreased appetite—Gefitinib—lung cancer	0.000374	0.00618	CcSEcCtD
Probenecid—Pain—Pemetrexed—lung cancer	0.00037	0.00612	CcSEcCtD
Probenecid—Pain—Gefitinib—lung cancer	0.000368	0.00608	CcSEcCtD
Probenecid—ABCC5—bone marrow—lung cancer	0.000364	0.0156	CbGeAlD
Probenecid—ABCC4—bronchus—lung cancer	0.000354	0.0152	CbGeAlD
Probenecid—Urticaria—Pemetrexed—lung cancer	0.000344	0.00568	CcSEcCtD
Probenecid—Body temperature increased—Pemetrexed—lung cancer	0.000342	0.00565	CcSEcCtD
Probenecid—Erythema multiforme—Erlotinib—lung cancer	0.000342	0.00565	CcSEcCtD
Probenecid—Urticaria—Gefitinib—lung cancer	0.000342	0.00565	CcSEcCtD
Probenecid—Body temperature increased—Gefitinib—lung cancer	0.00034	0.00562	CcSEcCtD
Probenecid—Anorexia—Teniposide—lung cancer	0.000334	0.00552	CcSEcCtD
Probenecid—Alopecia—Vinblastine—lung cancer	0.000333	0.0055	CcSEcCtD
Probenecid—ABCC5—lung—lung cancer	0.00033	0.0141	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Gemcitabine—lung cancer	0.000327	0.00541	CcSEcCtD
Probenecid—Alopecia—Topotecan—lung cancer	0.000323	0.00534	CcSEcCtD
Probenecid—SLC22A5—respiratory system—lung cancer	0.000323	0.0138	CbGeAlD
Probenecid—SLC16A7—lymph node—lung cancer	0.000322	0.0138	CbGeAlD
Probenecid—Alopecia—Erlotinib—lung cancer	0.00032	0.00528	CcSEcCtD
Probenecid—Hypersensitivity—Pemetrexed—lung cancer	0.000319	0.00527	CcSEcCtD
Probenecid—Hypersensitivity—Gefitinib—lung cancer	0.000317	0.00524	CcSEcCtD
Probenecid—Dizziness—Crizotinib—lung cancer	0.000313	0.00518	CcSEcCtD
Probenecid—Pruritus—Pemetrexed—lung cancer	0.000306	0.00506	CcSEcCtD
Probenecid—Decreased appetite—Teniposide—lung cancer	0.000305	0.00504	CcSEcCtD
Probenecid—Pruritus—Gefitinib—lung cancer	0.000305	0.00503	CcSEcCtD
Probenecid—Anaemia—Vinblastine—lung cancer	0.000303	0.00501	CcSEcCtD
Probenecid—ABCC1—bronchus—lung cancer	0.000302	0.0129	CbGeAlD
Probenecid—Vomiting—Crizotinib—lung cancer	0.000301	0.00498	CcSEcCtD
Probenecid—SLC16A1—lung—lung cancer	0.0003	0.0129	CbGeAlD
Probenecid—Dermatitis—Crizotinib—lung cancer	0.000299	0.00493	CcSEcCtD
Probenecid—Anaemia—Topotecan—lung cancer	0.000295	0.00486	CcSEcCtD
Probenecid—Leukopenia—Vinblastine—lung cancer	0.000294	0.00485	CcSEcCtD
Probenecid—Flushing—Vinorelbine—lung cancer	0.000291	0.0048	CcSEcCtD
Probenecid—Dizziness—Pemetrexed—lung cancer	0.000286	0.00473	CcSEcCtD
Probenecid—Leukopenia—Topotecan—lung cancer	0.000285	0.00471	CcSEcCtD
Probenecid—SLCO1C1—lymph node—lung cancer	0.000283	0.0121	CbGeAlD
Probenecid—Nausea—Crizotinib—lung cancer	0.000282	0.00465	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—lung cancer	0.00028	0.00462	CcSEcCtD
Probenecid—Urticaria—Teniposide—lung cancer	0.000279	0.0046	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.000278	0.00459	CcSEcCtD
Probenecid—Body temperature increased—Teniposide—lung cancer	0.000277	0.00458	CcSEcCtD
Probenecid—ABCC3—lung—lung cancer	0.000277	0.0119	CbGeAlD
Probenecid—Alopecia—Vinorelbine—lung cancer	0.000277	0.00457	CcSEcCtD
Probenecid—Vomiting—Pemetrexed—lung cancer	0.000275	0.00455	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.000274	0.00453	CcSEcCtD
Probenecid—Vomiting—Gefitinib—lung cancer	0.000274	0.00452	CcSEcCtD
Probenecid—Dermatitis—Pemetrexed—lung cancer	0.000273	0.00451	CcSEcCtD
Probenecid—Dermatitis—Gefitinib—lung cancer	0.000271	0.00448	CcSEcCtD
Probenecid—ABCC1—trachea—lung cancer	0.000271	0.0116	CbGeAlD
Probenecid—Haematuria—Gemcitabine—lung cancer	0.000267	0.00441	CcSEcCtD
Probenecid—SLC22A5—bronchus—lung cancer	0.000266	0.0114	CbGeAlD
Probenecid—Anaphylactic shock—Topotecan—lung cancer	0.00026	0.00429	CcSEcCtD
Probenecid—Hypersensitivity—Teniposide—lung cancer	0.000259	0.00427	CcSEcCtD
Probenecid—Nausea—Pemetrexed—lung cancer	0.000257	0.00425	CcSEcCtD
Probenecid—Nausea—Gefitinib—lung cancer	0.000256	0.00422	CcSEcCtD
Probenecid—Anorexia—Vinblastine—lung cancer	0.000255	0.00421	CcSEcCtD
Probenecid—ABCC1—cardiac atrium—lung cancer	0.000255	0.0109	CbGeAlD
Probenecid—ABCC4—bone marrow—lung cancer	0.000252	0.0108	CbGeAlD
Probenecid—Anaemia—Vinorelbine—lung cancer	0.000252	0.00416	CcSEcCtD
Probenecid—Pruritus—Teniposide—lung cancer	0.000248	0.0041	CcSEcCtD
Probenecid—Anorexia—Topotecan—lung cancer	0.000248	0.00409	CcSEcCtD
Probenecid—Anorexia—Erlotinib—lung cancer	0.000245	0.00405	CcSEcCtD
Probenecid—Leukopenia—Vinorelbine—lung cancer	0.000244	0.00403	CcSEcCtD
Probenecid—Pollakiuria—Paclitaxel—lung cancer	0.000243	0.00401	CcSEcCtD
Probenecid—Aplastic anaemia—Methotrexate—lung cancer	0.000241	0.00397	CcSEcCtD
Probenecid—Flushing—Irinotecan—lung cancer	0.00024	0.00396	CcSEcCtD
Probenecid—SLC22A5—trachea—lung cancer	0.000238	0.0102	CbGeAlD
Probenecid—Erythema multiforme—Gemcitabine—lung cancer	0.000238	0.00393	CcSEcCtD
Probenecid—SLCO1A2—lung—lung cancer	0.000237	0.0102	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000237	0.00392	CcSEcCtD
Probenecid—Decreased appetite—Vinblastine—lung cancer	0.000233	0.00384	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.000233	0.00384	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.000232	0.00384	CcSEcCtD
Probenecid—Pain—Vinblastine—lung cancer	0.000229	0.00378	CcSEcCtD
Probenecid—ABCC4—lung—lung cancer	0.000228	0.00979	CbGeAlD
Probenecid—Alopecia—Irinotecan—lung cancer	0.000228	0.00377	CcSEcCtD
Probenecid—Decreased appetite—Topotecan—lung cancer	0.000226	0.00373	CcSEcCtD
Probenecid—ABCC5—lymph node—lung cancer	0.000225	0.00966	CbGeAlD
Probenecid—SLC22A5—cardiac atrium—lung cancer	0.000224	0.0096	CbGeAlD
Probenecid—Haematuria—Paclitaxel—lung cancer	0.000224	0.00369	CcSEcCtD
Probenecid—Decreased appetite—Erlotinib—lung cancer	0.000224	0.00369	CcSEcCtD
Probenecid—Vomiting—Teniposide—lung cancer	0.000223	0.00368	CcSEcCtD
Probenecid—Anaphylactic shock—Vinorelbine—lung cancer	0.000222	0.00367	CcSEcCtD
Probenecid—Pain—Topotecan—lung cancer	0.000222	0.00367	CcSEcCtD
Probenecid—Alopecia—Gemcitabine—lung cancer	0.000222	0.00367	CcSEcCtD
Probenecid—Dermatitis—Teniposide—lung cancer	0.000221	0.00365	CcSEcCtD
Probenecid—Pain—Erlotinib—lung cancer	0.00022	0.00363	CcSEcCtD
Probenecid—Headache—Teniposide—lung cancer	0.00022	0.00363	CcSEcCtD
Probenecid—Flushing—Cisplatin—lung cancer	0.000218	0.00359	CcSEcCtD
Probenecid—Anorexia—Vinorelbine—lung cancer	0.000212	0.0035	CcSEcCtD
Probenecid—Nausea—Teniposide—lung cancer	0.000208	0.00344	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—lung cancer	0.000208	0.00344	CcSEcCtD
Probenecid—Anaemia—Irinotecan—lung cancer	0.000208	0.00343	CcSEcCtD
Probenecid—Alopecia—Cisplatin—lung cancer	0.000207	0.00342	CcSEcCtD
Probenecid—Urticaria—Topotecan—lung cancer	0.000207	0.00341	CcSEcCtD
Probenecid—Body temperature increased—Topotecan—lung cancer	0.000206	0.0034	CcSEcCtD
Probenecid—SLC16A1—lymph node—lung cancer	0.000205	0.00879	CbGeAlD
Probenecid—Body temperature increased—Erlotinib—lung cancer	0.000203	0.00336	CcSEcCtD
Probenecid—Erythema multiforme—Etoposide—lung cancer	0.000203	0.00335	CcSEcCtD
Probenecid—Anaemia—Gemcitabine—lung cancer	0.000202	0.00334	CcSEcCtD
Probenecid—Leukopenia—Irinotecan—lung cancer	0.000201	0.00332	CcSEcCtD
Probenecid—Flushing—Etoposide—lung cancer	0.000199	0.00329	CcSEcCtD
Probenecid—Erythema multiforme—Paclitaxel—lung cancer	0.000199	0.00329	CcSEcCtD
Probenecid—Hypersensitivity—Vinblastine—lung cancer	0.000197	0.00326	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000197	0.00326	CcSEcCtD
Probenecid—Leukopenia—Gemcitabine—lung cancer	0.000196	0.00324	CcSEcCtD
Probenecid—Flushing—Paclitaxel—lung cancer	0.000195	0.00323	CcSEcCtD
Probenecid—ABCC1—lung—lung cancer	0.000195	0.00835	CbGeAlD
Probenecid—Decreased appetite—Vinorelbine—lung cancer	0.000193	0.00319	CcSEcCtD
Probenecid—Hypersensitivity—Topotecan—lung cancer	0.000192	0.00316	CcSEcCtD
Probenecid—Pain—Vinorelbine—lung cancer	0.00019	0.00314	CcSEcCtD
Probenecid—Alopecia—Etoposide—lung cancer	0.00019	0.00313	CcSEcCtD
Probenecid—ABCC3—lymph node—lung cancer	0.000189	0.00811	CbGeAlD
Probenecid—Anaemia—Cisplatin—lung cancer	0.000189	0.00312	CcSEcCtD
Probenecid—Alopecia—Paclitaxel—lung cancer	0.000186	0.00307	CcSEcCtD
Probenecid—Pruritus—Topotecan—lung cancer	0.000184	0.00304	CcSEcCtD
Probenecid—Anaphylactic shock—Irinotecan—lung cancer	0.000183	0.00303	CcSEcCtD
Probenecid—Leukopenia—Cisplatin—lung cancer	0.000183	0.00302	CcSEcCtD
Probenecid—Pruritus—Erlotinib—lung cancer	0.000182	0.00301	CcSEcCtD
Probenecid—Anaphylactic shock—Gemcitabine—lung cancer	0.000179	0.00295	CcSEcCtD
Probenecid—Dizziness—Vinblastine—lung cancer	0.000177	0.00292	CcSEcCtD
Probenecid—Urticaria—Vinorelbine—lung cancer	0.000177	0.00292	CcSEcCtD
Probenecid—Body temperature increased—Vinorelbine—lung cancer	0.000176	0.0029	CcSEcCtD
Probenecid—Anorexia—Irinotecan—lung cancer	0.000175	0.00289	CcSEcCtD
Probenecid—Anaemia—Etoposide—lung cancer	0.000173	0.00285	CcSEcCtD
Probenecid—Dizziness—Topotecan—lung cancer	0.000172	0.00284	CcSEcCtD
Probenecid—SLC22A5—lung—lung cancer	0.000171	0.00734	CbGeAlD
Probenecid—Anorexia—Gemcitabine—lung cancer	0.00017	0.00281	CcSEcCtD
Probenecid—Vomiting—Vinblastine—lung cancer	0.00017	0.00281	CcSEcCtD
Probenecid—Dizziness—Erlotinib—lung cancer	0.00017	0.00281	CcSEcCtD
Probenecid—Anaemia—Paclitaxel—lung cancer	0.000169	0.0028	CcSEcCtD
Probenecid—Erythema multiforme—Docetaxel—lung cancer	0.000169	0.00279	CcSEcCtD
Probenecid—Headache—Vinblastine—lung cancer	0.000168	0.00277	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000167	0.00277	CcSEcCtD
Probenecid—Leukopenia—Etoposide—lung cancer	0.000167	0.00276	CcSEcCtD
Probenecid—Anaphylactic shock—Cisplatin—lung cancer	0.000167	0.00275	CcSEcCtD
Probenecid—Flushing—Docetaxel—lung cancer	0.000166	0.00274	CcSEcCtD
Probenecid—Vomiting—Topotecan—lung cancer	0.000165	0.00273	CcSEcCtD
Probenecid—Leukopenia—Paclitaxel—lung cancer	0.000164	0.00271	CcSEcCtD
Probenecid—Hypersensitivity—Vinorelbine—lung cancer	0.000164	0.00271	CcSEcCtD
Probenecid—Dermatitis—Topotecan—lung cancer	0.000164	0.00271	CcSEcCtD
Probenecid—Vomiting—Erlotinib—lung cancer	0.000164	0.0027	CcSEcCtD
Probenecid—Headache—Topotecan—lung cancer	0.000163	0.00269	CcSEcCtD
Probenecid—Dermatitis—Erlotinib—lung cancer	0.000162	0.00268	CcSEcCtD
Probenecid—ALB—lymph node—lung cancer	0.000161	0.00692	CbGeAlD
Probenecid—Headache—Erlotinib—lung cancer	0.000161	0.00266	CcSEcCtD
Probenecid—Decreased appetite—Irinotecan—lung cancer	0.00016	0.00263	CcSEcCtD
Probenecid—Nausea—Vinblastine—lung cancer	0.000159	0.00263	CcSEcCtD
Probenecid—Anorexia—Cisplatin—lung cancer	0.000159	0.00262	CcSEcCtD
Probenecid—Alopecia—Docetaxel—lung cancer	0.000158	0.00261	CcSEcCtD
Probenecid—Pruritus—Vinorelbine—lung cancer	0.000157	0.0026	CcSEcCtD
Probenecid—Pain—Irinotecan—lung cancer	0.000157	0.00259	CcSEcCtD
Probenecid—ABCC4—lymph node—lung cancer	0.000156	0.0067	CbGeAlD
Probenecid—Decreased appetite—Gemcitabine—lung cancer	0.000155	0.00257	CcSEcCtD
Probenecid—Nausea—Topotecan—lung cancer	0.000154	0.00255	CcSEcCtD
Probenecid—Pain—Gemcitabine—lung cancer	0.000153	0.00252	CcSEcCtD
Probenecid—Nausea—Erlotinib—lung cancer	0.000153	0.00252	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—lung cancer	0.000153	0.00252	CcSEcCtD
Probenecid—ABCC2—lymph node—lung cancer	0.000151	0.00648	CbGeAlD
Probenecid—ABCB1—respiratory system—lung cancer	0.00015	0.00642	CbGeAlD
Probenecid—Anaphylactic shock—Paclitaxel—lung cancer	0.00015	0.00247	CcSEcCtD
Probenecid—Dizziness—Vinorelbine—lung cancer	0.000147	0.00243	CcSEcCtD
Probenecid—Anorexia—Etoposide—lung cancer	0.000145	0.0024	CcSEcCtD
Probenecid—Body temperature increased—Irinotecan—lung cancer	0.000145	0.0024	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000145	0.00239	CcSEcCtD
Probenecid—Decreased appetite—Cisplatin—lung cancer	0.000145	0.00239	CcSEcCtD
Probenecid—Anaemia—Docetaxel—lung cancer	0.000144	0.00237	CcSEcCtD
Probenecid—Anorexia—Paclitaxel—lung cancer	0.000143	0.00236	CcSEcCtD
Probenecid—Pain—Cisplatin—lung cancer	0.000142	0.00235	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000142	0.00235	CcSEcCtD
Probenecid—Vomiting—Vinorelbine—lung cancer	0.000141	0.00234	CcSEcCtD
Probenecid—Body temperature increased—Gemcitabine—lung cancer	0.000141	0.00233	CcSEcCtD
Probenecid—Dermatitis—Vinorelbine—lung cancer	0.00014	0.00231	CcSEcCtD
Probenecid—Headache—Vinorelbine—lung cancer	0.000139	0.0023	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—lung cancer	0.000139	0.0023	CcSEcCtD
Probenecid—Haematuria—Methotrexate—lung cancer	0.000137	0.00226	CcSEcCtD
Probenecid—Hypersensitivity—Irinotecan—lung cancer	0.000135	0.00223	CcSEcCtD
Probenecid—ABCC1—lymph node—lung cancer	0.000133	0.00571	CbGeAlD
Probenecid—Decreased appetite—Etoposide—lung cancer	0.000133	0.00219	CcSEcCtD
Probenecid—Nausea—Vinorelbine—lung cancer	0.000132	0.00218	CcSEcCtD
Probenecid—Body temperature increased—Cisplatin—lung cancer	0.000132	0.00217	CcSEcCtD
Probenecid—Pain—Etoposide—lung cancer	0.000131	0.00216	CcSEcCtD
Probenecid—Decreased appetite—Paclitaxel—lung cancer	0.00013	0.00215	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—lung cancer	0.000129	0.00212	CcSEcCtD
Probenecid—Pain—Paclitaxel—lung cancer	0.000128	0.00211	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—lung cancer	0.000127	0.00209	CcSEcCtD
Probenecid—Pruritus—Gemcitabine—lung cancer	0.000126	0.00209	CcSEcCtD
Probenecid—ABCB1—epithelium—lung cancer	0.000125	0.00536	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000123	0.00203	CcSEcCtD
Probenecid—Hypersensitivity—Cisplatin—lung cancer	0.000123	0.00203	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—lung cancer	0.000122	0.00201	CcSEcCtD
Probenecid—Dizziness—Irinotecan—lung cancer	0.000121	0.002	CcSEcCtD
Probenecid—Urticaria—Etoposide—lung cancer	0.000121	0.002	CcSEcCtD
Probenecid—Anorexia—Docetaxel—lung cancer	0.000121	0.002	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—lung cancer	0.000121	0.00199	CcSEcCtD
Probenecid—Urticaria—Paclitaxel—lung cancer	0.000119	0.00196	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—lung cancer	0.000118	0.00195	CcSEcCtD
Probenecid—Body temperature increased—Paclitaxel—lung cancer	0.000118	0.00195	CcSEcCtD
Probenecid—SLC22A5—lymph node—lung cancer	0.000117	0.00502	CbGeAlD
Probenecid—Vomiting—Irinotecan—lung cancer	0.000117	0.00193	CcSEcCtD
Probenecid—Dermatitis—Irinotecan—lung cancer	0.000116	0.00191	CcSEcCtD
Probenecid—Headache—Irinotecan—lung cancer	0.000115	0.0019	CcSEcCtD
Probenecid—Alopecia—Methotrexate—lung cancer	0.000114	0.00188	CcSEcCtD
Probenecid—Vomiting—Gemcitabine—lung cancer	0.000114	0.00188	CcSEcCtD
Probenecid—Dermatitis—Gemcitabine—lung cancer	0.000113	0.00186	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—lung cancer	0.000112	0.00186	CcSEcCtD
Probenecid—Headache—Gemcitabine—lung cancer	0.000112	0.00185	CcSEcCtD
Probenecid—ABCB1—trachea—lung cancer	0.000111	0.00474	CbGeAlD
Probenecid—Decreased appetite—Docetaxel—lung cancer	0.00011	0.00182	CcSEcCtD
Probenecid—Hypersensitivity—Paclitaxel—lung cancer	0.00011	0.00182	CcSEcCtD
Probenecid—Nausea—Irinotecan—lung cancer	0.000109	0.0018	CcSEcCtD
Probenecid—Pain—Docetaxel—lung cancer	0.000108	0.00179	CcSEcCtD
Probenecid—Pruritus—Etoposide—lung cancer	0.000108	0.00178	CcSEcCtD
Probenecid—Nausea—Gemcitabine—lung cancer	0.000106	0.00175	CcSEcCtD
Probenecid—Vomiting—Cisplatin—lung cancer	0.000106	0.00175	CcSEcCtD
Probenecid—Pruritus—Paclitaxel—lung cancer	0.000106	0.00175	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—lung cancer	0.000105	0.00174	CcSEcCtD
Probenecid—Dermatitis—Cisplatin—lung cancer	0.000105	0.00173	CcSEcCtD
Probenecid—Anaemia—Methotrexate—lung cancer	0.000104	0.00171	CcSEcCtD
Probenecid—Flushing—Doxorubicin—lung cancer	0.000103	0.00171	CcSEcCtD
Probenecid—Dizziness—Etoposide—lung cancer	0.000101	0.00167	CcSEcCtD
Probenecid—Body temperature increased—Docetaxel—lung cancer	0.0001	0.00166	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—lung cancer	0.0001	0.00166	CcSEcCtD
Probenecid—Dizziness—Paclitaxel—lung cancer	9.9e-05	0.00163	CcSEcCtD
Probenecid—Nausea—Cisplatin—lung cancer	9.9e-05	0.00163	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—lung cancer	9.85e-05	0.00163	CcSEcCtD
Probenecid—Vomiting—Etoposide—lung cancer	9.7e-05	0.0016	CcSEcCtD
Probenecid—Dermatitis—Etoposide—lung cancer	9.61e-05	0.00159	CcSEcCtD
Probenecid—Headache—Etoposide—lung cancer	9.56e-05	0.00158	CcSEcCtD
Probenecid—Vomiting—Paclitaxel—lung cancer	9.51e-05	0.00157	CcSEcCtD
Probenecid—Dermatitis—Paclitaxel—lung cancer	9.43e-05	0.00156	CcSEcCtD
Probenecid—Headache—Paclitaxel—lung cancer	9.37e-05	0.00155	CcSEcCtD
Probenecid—Hypersensitivity—Docetaxel—lung cancer	9.34e-05	0.00154	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—lung cancer	9.14e-05	0.00151	CcSEcCtD
Probenecid—Nausea—Etoposide—lung cancer	9.07e-05	0.0015	CcSEcCtD
Probenecid—Pruritus—Docetaxel—lung cancer	8.97e-05	0.00148	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—lung cancer	8.96e-05	0.00148	CcSEcCtD
Probenecid—Nausea—Paclitaxel—lung cancer	8.89e-05	0.00147	CcSEcCtD
Probenecid—ABCB1—bone marrow—lung cancer	8.78e-05	0.00376	CbGeAlD
Probenecid—Anorexia—Methotrexate—lung cancer	8.71e-05	0.00144	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—lung cancer	8.68e-05	0.00143	CcSEcCtD
Probenecid—Dizziness—Docetaxel—lung cancer	8.39e-05	0.00139	CcSEcCtD
Probenecid—Vomiting—Docetaxel—lung cancer	8.06e-05	0.00133	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—lung cancer	7.99e-05	0.00132	CcSEcCtD
Probenecid—ABCB1—lung—lung cancer	7.95e-05	0.00341	CbGeAlD
Probenecid—Decreased appetite—Methotrexate—lung cancer	7.95e-05	0.00131	CcSEcCtD
Probenecid—Headache—Docetaxel—lung cancer	7.95e-05	0.00131	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—lung cancer	7.92e-05	0.00131	CcSEcCtD
Probenecid—Pain—Methotrexate—lung cancer	7.82e-05	0.00129	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—lung cancer	7.55e-05	0.00125	CcSEcCtD
Probenecid—Nausea—Docetaxel—lung cancer	7.53e-05	0.00124	CcSEcCtD
Probenecid—Urticaria—Methotrexate—lung cancer	7.26e-05	0.0012	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—lung cancer	7.23e-05	0.00119	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—lung cancer	6.88e-05	0.00114	CcSEcCtD
Probenecid—Pain—Doxorubicin—lung cancer	6.77e-05	0.00112	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—lung cancer	6.74e-05	0.00111	CcSEcCtD
Probenecid—Pruritus—Methotrexate—lung cancer	6.47e-05	0.00107	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—lung cancer	6.29e-05	0.00104	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—lung cancer	6.26e-05	0.00103	CcSEcCtD
Probenecid—Dizziness—Methotrexate—lung cancer	6.05e-05	0.000998	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—lung cancer	5.83e-05	0.000963	CcSEcCtD
Probenecid—Vomiting—Methotrexate—lung cancer	5.81e-05	0.00096	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—lung cancer	5.76e-05	0.000951	CcSEcCtD
Probenecid—Headache—Methotrexate—lung cancer	5.73e-05	0.000946	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—lung cancer	5.6e-05	0.000925	CcSEcCtD
Probenecid—ABCB1—lymph node—lung cancer	5.44e-05	0.00233	CbGeAlD
Probenecid—Nausea—Methotrexate—lung cancer	5.43e-05	0.000897	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—lung cancer	5.23e-05	0.000864	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—lung cancer	5.03e-05	0.000831	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—lung cancer	4.99e-05	0.000823	CcSEcCtD
Probenecid—Headache—Doxorubicin—lung cancer	4.96e-05	0.000819	CcSEcCtD
Probenecid—Nausea—Doxorubicin—lung cancer	4.7e-05	0.000776	CcSEcCtD
Probenecid—CYP2C9—Metabolism—CYP2A6—lung cancer	2.39e-06	2.55e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GCLC—lung cancer	2.39e-06	2.55e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CREBBP—lung cancer	2.39e-06	2.55e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—lung cancer	2.39e-06	2.55e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.38e-06	2.54e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.38e-06	2.54e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTOR—lung cancer	2.36e-06	2.51e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CB—lung cancer	2.36e-06	2.51e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—lung cancer	2.35e-06	2.51e-05	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	2.34e-06	2.5e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—lung cancer	2.34e-06	2.49e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—lung cancer	2.3e-06	2.45e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOA1—lung cancer	2.29e-06	2.44e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—B4GALT5—lung cancer	2.28e-06	2.43e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.27e-06	2.42e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ENO1—lung cancer	2.27e-06	2.42e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CD—lung cancer	2.26e-06	2.42e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.26e-06	2.41e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—lung cancer	2.24e-06	2.39e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—lung cancer	2.24e-06	2.38e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP2E1—lung cancer	2.23e-06	2.38e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.23e-06	2.38e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—STK11—lung cancer	2.23e-06	2.38e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—lung cancer	2.22e-06	2.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—STK11—lung cancer	2.22e-06	2.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA4—lung cancer	2.21e-06	2.36e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NQO1—lung cancer	2.21e-06	2.35e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—lung cancer	2.2e-06	2.35e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CB—lung cancer	2.19e-06	2.34e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—EP300—lung cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2E1—lung cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—lung cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—lung cancer	2.17e-06	2.32e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.16e-06	2.3e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA2—lung cancer	2.16e-06	2.3e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NQO1—lung cancer	2.15e-06	2.3e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.14e-06	2.28e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—POMC—lung cancer	2.14e-06	2.28e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SRC—lung cancer	2.12e-06	2.26e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.09e-06	2.23e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—lung cancer	2.09e-06	2.23e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—lung cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA1—lung cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CREBBP—lung cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—EP300—lung cancer	2.08e-06	2.21e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—lung cancer	2.06e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—lung cancer	2.06e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCC3—lung cancer	2.06e-06	2.2e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.05e-06	2.19e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—lung cancer	2.05e-06	2.19e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1A—lung cancer	2.04e-06	2.18e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—lung cancer	2.04e-06	2.17e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—lung cancer	2.04e-06	2.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2E1—lung cancer	2.03e-06	2.17e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—lung cancer	2.03e-06	2.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NQO1—lung cancer	2.01e-06	2.15e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAT—lung cancer	2.01e-06	2.14e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAT—lung cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKR1C1—lung cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—POMC—lung cancer	1.99e-06	2.12e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—STK11—lung cancer	1.99e-06	2.12e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—lung cancer	1.97e-06	2.11e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—lung cancer	1.97e-06	2.1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.97e-06	2.1e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—lung cancer	1.96e-06	2.09e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.95e-06	2.08e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—lung cancer	1.95e-06	2.08e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—lung cancer	1.95e-06	2.08e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—lung cancer	1.95e-06	2.08e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EP300—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—STK11—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CREBBP—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—lung cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—UGT1A1—lung cancer	1.94e-06	2.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TYMS—lung cancer	1.92e-06	2.04e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—TYMS—lung cancer	1.91e-06	2.03e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—lung cancer	1.9e-06	2.02e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—lung cancer	1.89e-06	2.02e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—lung cancer	1.89e-06	2.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—lung cancer	1.88e-06	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.87e-06	1.99e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNG11—lung cancer	1.87e-06	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—lung cancer	1.84e-06	1.96e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—lung cancer	1.84e-06	1.96e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—lung cancer	1.82e-06	1.94e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—lung cancer	1.82e-06	1.94e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—lung cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—STK11—lung cancer	1.81e-06	1.93e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—EP300—lung cancer	1.81e-06	1.93e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—lung cancer	1.8e-06	1.92e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A1—lung cancer	1.8e-06	1.92e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAT—lung cancer	1.79e-06	1.91e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A1—lung cancer	1.79e-06	1.9e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ERCC2—lung cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDOA—lung cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ERCC2—lung cancer	1.77e-06	1.89e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—lung cancer	1.75e-06	1.87e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAT—lung cancer	1.75e-06	1.86e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—lung cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—lung cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA3—lung cancer	1.73e-06	1.84e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—lung cancer	1.72e-06	1.83e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TYMS—lung cancer	1.71e-06	1.82e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—lung cancer	1.71e-06	1.82e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—lung cancer	1.7e-06	1.82e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.7e-06	1.82e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—lung cancer	1.7e-06	1.82e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—lung cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—lung cancer	1.69e-06	1.8e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADCY1—lung cancer	1.68e-06	1.79e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCG2—lung cancer	1.68e-06	1.79e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—lung cancer	1.68e-06	1.79e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TYMS—lung cancer	1.67e-06	1.78e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—lung cancer	1.66e-06	1.77e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—lung cancer	1.65e-06	1.76e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HPGDS—lung cancer	1.65e-06	1.76e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO2—lung cancer	1.65e-06	1.76e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.64e-06	1.74e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAT—lung cancer	1.63e-06	1.74e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—EP300—lung cancer	1.63e-06	1.74e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.62e-06	1.73e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—lung cancer	1.61e-06	1.72e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A1—lung cancer	1.6e-06	1.71e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—lung cancer	1.6e-06	1.71e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—lung cancer	1.6e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ERCC2—lung cancer	1.59e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—lung cancer	1.59e-06	1.69e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—lung cancer	1.59e-06	1.69e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—lung cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCLC—lung cancer	1.58e-06	1.68e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2A6—lung cancer	1.58e-06	1.68e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A1—lung cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—lung cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMS—lung cancer	1.56e-06	1.66e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—lung cancer	1.56e-06	1.66e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ERCC2—lung cancer	1.55e-06	1.66e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—lung cancer	1.54e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOA1—lung cancer	1.54e-06	1.64e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—lung cancer	1.54e-06	1.64e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOA1—lung cancer	1.53e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO1—lung cancer	1.5e-06	1.6e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—lung cancer	1.49e-06	1.59e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—lung cancer	1.49e-06	1.58e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.48e-06	1.57e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.47e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A1—lung cancer	1.46e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ERCC2—lung cancer	1.45e-06	1.55e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—lung cancer	1.44e-06	1.53e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—EP300—lung cancer	1.42e-06	1.51e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—lung cancer	1.41e-06	1.5e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—lung cancer	1.4e-06	1.49e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—lung cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOA1—lung cancer	1.38e-06	1.47e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOA1—lung cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2E1—lung cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POMC—lung cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—lung cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—POMC—lung cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—lung cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NQO1—lung cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—EP300—lung cancer	1.32e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.32e-06	1.4e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—lung cancer	1.32e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CREBBP—lung cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CREBBP—lung cancer	1.3e-06	1.38e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—lung cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—lung cancer	1.26e-06	1.34e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—lung cancer	1.25e-06	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOA1—lung cancer	1.25e-06	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—lung cancer	1.24e-06	1.32e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—lung cancer	1.23e-06	1.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—lung cancer	1.23e-06	1.31e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—lung cancer	1.22e-06	1.3e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—lung cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STK11—lung cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POMC—lung cancer	1.2e-06	1.27e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—lung cancer	1.17e-06	1.25e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POMC—lung cancer	1.17e-06	1.24e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CREBBP—lung cancer	1.16e-06	1.24e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—lung cancer	1.15e-06	1.22e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CREBBP—lung cancer	1.14e-06	1.21e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—lung cancer	1.11e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—lung cancer	1.1e-06	1.18e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—lung cancer	1.09e-06	1.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POMC—lung cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—lung cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—lung cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—lung cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAT—lung cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—lung cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—lung cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—lung cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—lung cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CREBBP—lung cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—lung cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—lung cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMS—lung cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—lung cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—lung cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—lung cancer	9.94e-07	1.06e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—lung cancer	9.83e-07	1.05e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—lung cancer	9.77e-07	1.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A1—lung cancer	9.64e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—lung cancer	9.62e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ERCC2—lung cancer	9.56e-07	1.02e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—lung cancer	9.53e-07	1.02e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—lung cancer	9.39e-07	1e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—lung cancer	9.32e-07	9.94e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—lung cancer	9.31e-07	9.93e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—lung cancer	9.26e-07	9.88e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—EP300—lung cancer	8.88e-07	9.48e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—EP300—lung cancer	8.83e-07	9.42e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—lung cancer	8.77e-07	9.36e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—lung cancer	8.69e-07	9.27e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—lung cancer	8.56e-07	9.13e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—lung cancer	8.31e-07	8.87e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOA1—lung cancer	8.27e-07	8.82e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—lung cancer	8.12e-07	8.66e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—lung cancer	7.98e-07	8.51e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—EP300—lung cancer	7.93e-07	8.46e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—EP300—lung cancer	7.74e-07	8.26e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—lung cancer	7.58e-07	8.09e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—lung cancer	7.55e-07	8.05e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—EP300—lung cancer	7.23e-07	7.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POMC—lung cancer	7.19e-07	7.67e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CREBBP—lung cancer	7e-07	7.47e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—lung cancer	6.64e-07	7.08e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—lung cancer	6.57e-07	7.01e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—lung cancer	6.55e-07	6.99e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—lung cancer	6.53e-07	6.97e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—lung cancer	5.87e-07	6.26e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—lung cancer	5.79e-07	6.17e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—lung cancer	5.73e-07	6.12e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—lung cancer	5.73e-07	6.11e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—lung cancer	5.37e-07	5.73e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—lung cancer	5.35e-07	5.7e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—lung cancer	5.34e-07	5.69e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—lung cancer	5e-07	5.33e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—lung cancer	4.79e-07	5.11e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—EP300—lung cancer	4.77e-07	5.09e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—lung cancer	4.68e-07	4.99e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—lung cancer	4.37e-07	4.66e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—lung cancer	3.53e-07	3.76e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—lung cancer	2.88e-07	3.07e-06	CbGpPWpGaD
